Boulding Mark Elliott bought PTCT
October 3, 2025 · Form 4 insider transaction
Boulding Mark Elliott bought 2,265 shares of PTC Therapeutics, Inc. at $39.42 per share, a transaction worth $89.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,265
Price
$39.42
Total value
$89.3K
InsiderBoulding Mark Elliott
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 3, 2025
Filing dateOctober 7, 2025
Shares owned after106,166
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024.